tiprankstipranks
Acasti Pharma, Inc. (ACST)
NASDAQ:ACST
Holding ACST?
Track your performance easily

Acasti Pharma (ACST) Technical Analysis

1,140 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Acasti Pharma, Inc.’s (ACST) Moving Averages Convergence Divergence (MACD) indicator is 0.10, suggesting Acasti Pharma, Inc. is a Buy.
Acasti Pharma, Inc.’s (ACST) 20-Day exponential moving average is 3.21, while Acasti Pharma, Inc.’s (ACST) share price is $3.37, making it a Sell.
Acasti Pharma, Inc.’s (ACST) 50-Day exponential moving average is 3.02, while Acasti Pharma, Inc.’s (ACST) share price is $3.37, making it a Buy.

Acasti Pharma (ACST) Pivot Points

Nov 21, 2024, 11:20 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.96
3.04
3.14
3.22
3.32
3.40
3.50
Fibonacci
3.04
3.11
3.15
3.22
3.29
3.33
3.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Acasti Pharma (ACST) Moving Averages

Nov 21, 2024, 11:20 PM
Period
Simple
Exponential
MA5
3.26Sell
3.23Sell
MA10
3.30Sell
3.27Sell
MA20
3.27Sell
3.21Sell
MA50
2.87Buy
3.02Buy
MA100
2.87Buy
2.91Buy
MA200
2.92Buy
2.85Buy
Acasti Pharma, Inc.’s (ACST) 10-Day exponential moving average is 3.27, while Acasti Pharma, Inc.’s (ACST) share price is $3.37, making it a Sell.
Acasti Pharma, Inc.’s (ACST) 100-Day exponential moving average is 2.91, while Acasti Pharma, Inc.’s (ACST) share price is $3.37, making it a Buy.
Acasti Pharma, Inc.’s (ACST) stock price is $3.37 and Acasti Pharma, Inc.’s (ACST) 50-day simple moving average is 2.87, creating a Buy signal.
Acasti Pharma, Inc.’s (ACST) stock price is $3.37 and Acasti Pharma, Inc.’s (ACST) 100-day simple moving average is 2.87, creating a Buy signal.
Acasti Pharma, Inc.’s (ACST) stock price is $3.37 and Acasti Pharma, Inc.’s (ACST) 200-day simple moving average is 2.92, creating a Buy signal.

Acasti Pharma (ACST) Technical Indicators

Nov 21, 2024, 11:20 PM
Name
Value
Implied Action
RSI (14)
47.98
Neutral
STOCH (9,6)
35.90
Neutral
STOCHRSI (14)
35.90
Neutral
MACD (12,26)
0.10
Buy
ADX (14)
24.20
Neutral
Williams %R
-76.92
Buy
CCI (14)
-52.42
Neutral
ATR (14)
0.22
-
Ultimate Oscillator
61.27
Neutral
ROC
-9.09
Sell
Acasti Pharma, Inc.’s (ACST) Relative Strength Index (RSI) is 47.98, creating a Neutral signal.
Acasti Pharma, Inc.’s (ACST) Trend Strength Indicator (ADX) is 24.20, creating a Neutral signal.
Acasti Pharma, Inc.’s (ACST) Commodity Channel Index (CCI) is -52.42, creating a Neutral signal.
Acasti Pharma, Inc.’s (ACST) Price Rate of Change (ROC) is -9.09, creating a Sell signal.

FAQ

Is ACST a Buy, Hold, or Sell?
Based on ACST’s technical indicators, ACST is a Hold.
    What is ACST’s RSI (14)?
    ACST’s RSI (14) is 47.98, which suggests ACST is a Neutral.
      What is ACST’s MACD?
      ACST’s MACD is 0.10, which suggests ACST is a Buy.
        What is ACST’s 5-day moving average?
        ACST’s 5-day moving average is 3.26, which suggests ACST is a Sell.
          What is ACST’s 20-day moving average?
          ACST 20-day moving average is 3.27, which suggests ACST is a Sell.
            What is ACST’s 50-day moving average?
            ACST’s 50-day moving average is 2.87, which suggests ACST is a Buy.
              What is ACST’s 200-day moving average?
              ACST’s 200-day moving average is 2.92, which suggests ACST is a Buy.
                What is ACST’s Williams % R (14)?
                ACST’s Williams % R (14) is -76.92, which suggests ACST is a Buy.
                  What is ACST’s CCI (14)?
                  ACST’s CCI (14) is -52.42, which suggests ACST is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis